Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment

The neuromuscular adverse events of immune checkpoint inhibitor (ICI) treatment include myositis, polymyalgia rheumatica, myocarditis, and myasthenia syndrome. We report a 47-year old female presenting with external ophthalmoplegia, generalized muscle weakness, and third-degree atrioventricular bloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yue-Bei, Tang, Weiting, Zeng, Qiuming, Duan, Weiwei, Li, Shuyu, Yang, Xiaosu, Bi, Fangfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415306/
https://www.ncbi.nlm.nih.gov/pubmed/34485412
http://dx.doi.org/10.3389/fcvm.2021.714460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415306/
https://www.ncbi.nlm.nih.gov/pubmed/34485412
http://dx.doi.org/10.3389/fcvm.2021.714460

Ejemplares similares